Successful treatment of transplant-associated microangiopathy with rituximab

New Zealand Medical Journal

Volumn 122, Issue 1292, 2009, Pages 72-74

  Marr, Helen ^a   McDonald, Emma Jane ^a   Merriman, Eileen ^a   Smith, Mark ^a   Mangos, Hilda ^b   Stoddart, Catherine ^c   Ganly, Peter ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b DUNEDIN HOSPITAL   (New Zealand)

^c Southern Community Laboratories   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID DERIVATIVE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GANCICLOVIR; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; THYMOCYTE ANTIBODY; MONOCLONAL ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APHASIA; APLASTIC ANEMIA; ARTICLE; BRAIN HEMORRHAGE; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ENTEROPATHY; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; SKIN DISEASE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; HEMOLYTIC ANEMIA; HOSPITALIZATION; LETTER; METHODOLOGY; RISK ASSESSMENT;

ADULT; ANEMIA, APLASTIC; ANEMIA, HEMOLYTIC; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 66949117062     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. George JN. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927-35.
2. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting? Bone Marrow Transplant. 2007;40:709-19.
3. Au W-Y, Ma ES, Lee T-L, et al. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol. 2007;137:475-8.
4. Ostronoff M, Ostronoff F, Calixto R, et al. Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant. 2007;39:649-51.
5. Ruutu T, Barosi G, Benjamin RJ, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: Results of a consensus process by an International Working Group. Haematologica. 2007;92:95-100.
6. Schriber JR, Herzig GP. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol. 1997;34:126-33.